Navigation Links
Global conference on stem cell therapy for heart disease to be held Jan. 25-27 in NYC
Date:1/23/2012

hed in The Lancet showed that intracoronary infusion of autologous CSCs results in a striking improvement in left ventricular ejection fraction, NYHA functional class, quality of life, and in a significant reduction in infarct size.

  • CD34+ Cells for Refractory Angina: ACT 34 CMI Update and Phase 3 Study Design
    Thursday, January 26, 2012; 10:45 AM

    Dr. Timothy Henry will discuss results of the ACT 34 trial, the largest randomized, placebo-controlled, double-blind trial of CD34+ cell therapy for the treatment of patients with class III/IV refractory angina. Dr. Henry will also discuss the study design of a planned Phase III trial set to begin in 2012.

  • SDF-1 for Heart Failure: Results of a Phase I Trial
    Thursday, January 26, 2012; 1:30 PM

    Dr. Marc Penn will present 1-year clinical data results of a plasmid encoding human SDF-1 protein in patients with chronic heart failure. SDF-1 has been identified as a key regulator of stem cell trafficking to sites of cardiac injury and could potentially be used to treat chronic heart failure. Investigators initially found that after four months, patients exhibited clinically significant improvements in quality of life, six-minute walk distance, decreased heart failure symptoms and stabilization of myocardial function.

    The latest conference agenda is available at http://celltherapy.crf.org/conference/agenda.html.

    WHY: Now in its 11th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has seen many notable successes, as well as identified challenges that await the next round of clinical studies. Leaders in the field will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies.

    In addition, Friday's sessions will focus on developing a rational policy towards
    '/>"/>


  • Contact: Judy Romero
    jromero@crf.org
    Cardiovascular Research Foundation
    Source:Eurekalert

    Page: 1 2 3

    Related medicine news :

    1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
    2. International Diabetes Federation awards $2 million to 9 global diabetes research projects
    3. Virtual Global Highlights Top Ten Misconceptions about Cloud Computing
    4. Global Health Defined as Public Health in a New Lancet Commentary by the Association of Schools of Public Health (ASPH)
    5. Dr Yaghouti of Global Laser Vision Receives Patient's Choice Award for 2009
    6. Bioniche Achieves Two Additional Milestones Under Licensing Agreement; Endo Takes up Global Rights
    7. Now Serving 9 Billion: A Global Town Hall
    8. The Global Leaders' Inaugural Meeting a Resounding Success
    9. Language Service Leader Expands to Meet Booming, Global Industry Demand.
    10. GenomeQuest Hosts Seminar Focused On Web-based Searching for Patent Information Across Global Sequence Databases
    11. Global Nutrition Firm Takes Dose of SonicWALL to Boost Network Health
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... WA (PRWEB) April 17, 2015 ERGO-Pedic ... cushions is introducing two new products to help a ... low back pain relief are the second most common ... our first product, designed specifically to help relieve sitting ... Comfort Cushion, and thousands of happy customers later, we ...
    (Date:4/17/2015)... (PRWEB) April 17, 2015 Alcohol and ... Dependence (NCADD) notes that drinking and driving has been ... At the same time, the link between alcohol and ... domestic abuse and violence and sexual assault, and their ... to the NCADD, 5.3 million adults in America were ...
    (Date:4/17/2015)... 2015 “We have seen healing, a lot ... and present,” said Chaplain Shawn Kafader of Friendship Village. ... they had anything to contribute have created beautiful pieces of ... new art therapy program that was launched to benefit residents ... from School of the Art Institute in Chicago, worked as ...
    (Date:4/17/2015)... D.C. (PRWEB) April 17, 2015 In ... issued the following statement: “On Wednesday April 15th, the ... and adopted a resolution recognizing the Armenian Genocide, “paying ... memory of the one-and-a-half million innocent Armenian victims who ... Christians (IDC) extols the EU for this timely and ...
    (Date:4/17/2015)... (PRWEB) April 17, 2015 Representatives Jim ... Diagnoses and Treatment Act HR 1849 in congress on ... rates and treatment for patients with the genetic disease. ... the past, would be the first to create a ... appropriate treatment of hereditary hemorrhagic telangiectasia. This would effectively ...
    Breaking Medicine News(10 mins):Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:Healing At Friendship Village Due To Art Therapy 2Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:House Representatives Introduce Bill to Fight Genetic Disease 2
    ... which men are at increased risk, scientists say , MONDAY, ... identified key gene variants tied to an increased risk of ... step toward understanding which men are at high risk for ... not been any clear genetic risk factors that can account ...
    ... 1 Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, ... the companies have begun enrolling patients in an international ... patients with non-squamous non-small cell lung cancer (NSCLC) who ... , "Nexavar has proven efficacy in liver cancer and ...
    ... Two of the nation,s most rapidly growing retained physician search ... Inc., Atlanta, GA, have agreed to merge their operations under ... not disclosed. , , Crutchfield Capital Corporation served ... "Successful mergers are built upon cultural fit, the integrity of ...
    ... and response at national and local level , , ... $1 million over the next three years through the Ryder ... response efforts, making it the newest member of the American ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) , ...
    ... on Rebuilding Revenue Base While Stabilizing Costs--, ... /PRNewswire-FirstCall/ - Vancouver, BC, Canada - Neovasc Inc. (TSXV: NVC), ... 31, 2009. , "The first quarter continued to show financial ... Neovasc on our most promising growth areas," said Alexei Marko, ...
    ... clinical recommendations encourage cardiologists to examine the mouth and periodontists ... June 1 Cardiovascular disease, the leading killer of men ... health issue contributing to 2,400 deaths each day. Periodontal disease, ... that support the teeth affects nearly 75 percent of Americans ...
    Cached Medicine News:Health News:Researchers Spot Genes Linked to Testicular Cancer 2Health News:Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer 2Health News:Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer 3Health News:Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer 4Health News:Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer 5Health News:Unprecedented Merger Occurs in Retained Physician Search Industry 2Health News:Unprecedented Merger Occurs in Retained Physician Search Industry 3Health News:Ryder System, Inc. Joins the American Red Cross Annual Disaster Giving Program 2Health News:Ryder System, Inc. Joins the American Red Cross Annual Disaster Giving Program 3Health News:Ryder System, Inc. Joins the American Red Cross Annual Disaster Giving Program 4Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 2Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 3Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 4Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 5Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 6Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 7Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 8Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 9Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 10Health News:Neovasc Inc. Reports First Quarter 2009 Financial Results 11Health News:Healthy Gums and a Healthy Heart: The Perio-Cardio Connection 2Health News:Healthy Gums and a Healthy Heart: The Perio-Cardio Connection 3Health News:Healthy Gums and a Healthy Heart: The Perio-Cardio Connection 4
    (Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ) has ... - Global Strategic Business Report" report to their ... for Medical Oxygen Systems in US$ Thousands by the ... & Regulators, and Oxygen Conserving Devices. The report provides ... , Japan , ...
    (Date:4/17/2015)... 17, 2015   IBA Molecular, a global ... today that it has signed a definitive agreement to ... (IBAM NA), to Illinois Health and Science (IHS). Under IHS ... independent company headquartered in Dulles, Virginia ... of new product and footprint synergies. IBA Molecular is ...
    (Date:4/17/2015)... TAIPEI , April 17, 2015 TWi ... fully-owned subsidiary, TWi Pharmaceuticals USA , ... in the United States.  It has been in close ... wholesalers and expects to have its own label specialty ... soon in the U.S. pharma market. According ...
    Breaking Medicine Technology:Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3
    ... and Safety of Combination Drug Therapies -, ... Life,Sciences, Inc. (Nasdaq: CALP ) today ... & Services (CDAS). These new services,will help ... therapies,and identify potentially harmful combinations before therapies ...
    ... WILMINGTON, Del., Nov. 30 AstraZeneca (NYSE:,AZN) announced ... in the,ZEST (ZACTIMA Efficacy Study versus Tarceva) study, ... investigational once-daily oral anti-cancer drug,vandetanib. Data from the ... a randomized, double-blind, multi-center Phase III study to,assess ...
    Cached Medicine Technology:Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds 2AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer 2
    ... biopsies of soft tissue. Lightweight and compact, ... control. Precise, rapid firing mechanism provides intact ... easy penetration into the specimen with less ... of cannula helps assure an intact tissue ...
    ... The Bard EXPRESS Seeding Cartridge System is ... delivering radioactive seeds and spacers into a ... Each cartridge has a(n): outer radiation safety ... synthetic absorbable spacers, integrally molded fitting that ...
    ... very easy to use Ambulatory Urodynamic recorder ... with practising urologists as an invaluable aid ... dysfunctions. The system offers the possibility to ... a natural bladder filling, extented over a ...
    A compact mobile System Cart gives mobility within your department. The cart accomodates the Uromac Median data processor, desktop computer, printer and provides stowage space. Patient related transd...
    Medicine Products: